Telescope Innovations reports Q2 FY2026 revenue growth to $1.64M, driven by Self-Driving Labs and lithium tech progress.

Telescope Innovations Corp. posted Q2 FY2026 revenues of CAD 1.64 million, up from CAD 1.00 million last year, fueled by strong sales of its Self-Driving Laboratories, including a second unit delivered to Pfizer. The company reported an adjusted EBITA loss of CAD 0.71 million due to increased expenses supporting growth, such as hiring and product delivery costs. Operationally, Telescope expanded its lithium processing capabilities with new lab space and advanced recycling technology, confirming battery-grade lithium production viability. These developments position Telescope for continued technical and commercial growth throughout the fiscal year.